Mirna EXPRESSION SIGNATURES as PROGNOSTIC Markers IN ADVANCED Classical HODGKIN LYMPHOMA

被引：0
|
作者：
Sanchez-Espiridion, Beatriz [1 ]
Montalban, Carlos [2 ]
Guisado, Pablo [2 ]
Rodriguez, Maria E. [1 ]
Canales, Miguel [3 ]
Alves, Javier [3 ]
Vega, Francisco [4 ]
Morente, Manuel [5 ]
Francisco Tomas, Jose [6 ]
Piris, Miguel A. [1 ]
Garcia, Juan F. [6 ]
机构：
[1] Spanish Natl Canc Res Ctr, Lymphoma Grp, Madrid, Spain
[2] Hosp Ramon & Cajal, Dept Int Med, E-28034 Madrid, Spain
[3] Hosp Univ La Paz, Madrid, Spain
[4] UT MD Anderson Canc Cntr, Hemopath Unit 72, Houston, TX USA
[5] Spanish Natl Canc Res Ctr, Tumor Bank, Madrid, Spain
[6] MD Anderson, Madrid, Spain
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1692 / 1692
页数：1
相关论文
共 50 条
  • [41] Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
    Allen, Pamela B.
    Gordon, Leo I.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2017, 11
  • [42] Expression of ß-tubulin isotypes in classical Hodgkin's lymphoma
    Choi, Jung-Woo
    Lee, Ju-Han
    Kim, Young-Sik
    PATHOLOGY INTERNATIONAL, 2012, 62 (04) : 287 - 290
  • [43] REL protein expression in classical Hodgkin's lymphoma
    Xiao, Q
    Shen, N
    Hedvat, C
    Moskowitz, CH
    Zelenetz, AD
    Houldsworth, J
    Chaganti, RSK
    Teruya-Feldstein, J
    LABORATORY INVESTIGATION, 2003, 83 (01) : 259A - 259A
  • [44] Analysis of micrornas expression pattern in classical Hodgkin lymphoma
    Navarro, A.
    Gaya, A.
    Urbano-Ispizua, A.
    Pons, A.
    Martinez, A.
    Gel, B.
    Balague, O.
    Abrisqueta, P.
    Lopez-Guillermo, A.
    Artells, R.
    Montserrat, E.
    Monzo, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 344 - 345
  • [45] REL protein expression in classical Hodgkin's lymphoma
    Xiao, Q
    Shen, N
    Hedvat, C
    Moskowitz, CH
    Zelenetz, AD
    Houldsworth, J
    Chaganti, RSK
    Teruya-Feldstein, J
    MODERN PATHOLOGY, 2003, 16 (01) : 259A - 259A
  • [46] Fascin expression in classical Hodgkin lymphoma and anaplastic large cell lymphoma
    Boujelbene, N.
    Driss, M.
    Doghri, R.
    Abbes, I.
    Ben Hamida, N.
    Kacem, D.
    Mrad, K.
    Charfi, L.
    VIRCHOWS ARCHIV, 2019, 475 : S344 - S344
  • [47] Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma
    Reid, Justin H.
    Marini, Bernard L.
    Nachar, Victoria R.
    Brown, Anna M.
    Devata, Sumana
    Perissinotti, Anthony J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 148
  • [48] Prognostic Value of Immunohistochemical Angiogenic and Invasion Markers in Hodgkin Lymphoma
    Mestre, Francisco
    Gutierrez, Antonio
    Ramos, Rafael
    Casasus, M.
    Nicolau, C.
    Martinez, Jordi
    Besalduch, Juan
    Rifa, Julio
    Garcia, Juan Fernando
    Rodriguez, Jose
    BLOOD, 2008, 112 (11) : 521 - 521
  • [49] CLINICAL RELEVANCE OF HISTOLOGICAL VARIABLES IN ADVANCED CLASSICAL HODGKIN LYMPHOMA
    Jakovic, L. R.
    Mihaljevic, B.
    Jovanovic, M. Perunicic
    Bogdanovic, A.
    Bumbasirevic, V.
    ANNALS OF ONCOLOGY, 2011, 22 : 214 - 214
  • [50] New developments in the treatment of advanced classical Hodgkin's lymphoma
    Kreissl, S.
    Eichenauer, D. A.
    Meissner, J.
    Topp, M. S.
    Engert, A.
    Borchmann, P.
    ONKOLOGE, 2018, 24 (04): : 315 - 321
12345